Savella® milnacipran HClSavella® logo
Back to Patient Information Back to Patient Information
Pregnancy Registry Information Pregnancy Registry Information

INFORMATION FOR HEALTHCARE PROFESSIONALS

Offer your patients Savella for the management of fibromyalgia

Find Important Risk Information about Savella Find Important Risk Information about Savella
Healthcare Professionals Home
Clinical Studies

Clinical Studies

Savella has been extensively studied

Savella achieved positive outcomes in 4 of 4 efficacy studies involving nearly 4,000 patients

Clinical Study Experience Based on Fibromyalgia Trials

Efficacy established in adult patients who met American College of Rheumatology (ACR) criteria for fibromyalgia5
  • History of widespread pain for ≥3 months
  • Pain present at ≥11 of 18 specific tender points
NEXT: Important Safety Information next arrow

Savella (milnacipran HCl) is indicated for the management of fibromyalgia in adults. Savella is available by prescription only.

ISI

Please see full Prescribing Information.

References
  1. Clauw DJ, Mease P, Palmer RH, et al. Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial. Clin Ther. 2008;30(11):1988-2004.
  2. Mease PJ, Clauw DJ, Gendreau RM, et al. The efficacy and safety of milnacipran for treatment of fibromyalgia: a randomized, double-blind, placebo-controlled trial. J Rheumatol. 2009;36(2) :398-409.
  3. Arnold LM, Gendreau RM, Palmer RH, et al. Efficacy and safety of milnacipran 100 mg/day in patients with fibromyalgia: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2010;62(9):2745-2756.
  4. Branco JC, Zachrisson O, Perrot S, et al, on behalf of the Multinational Coordinator Study Group. A European, multicenter, randomized, double-blind, placebo-controlled monotherapy clinical trial of milnacipran in treatment of fibromyalgia. J Rheumatol. 2010;37(4):851-859.
  5. Savella (milnacipran HCl) prescribing information. Forest Pharmaceuticals, Inc. St Louis, MO.
Thank you for visiting

You are now leaving Savella.com

Please note: Forest Laboratories, Inc. is not responsible for the content or services on the site you will now visit.

GO BACK
CONTINUE
Pregnancy Registry Information

For information about the Savella Pregnancy Registry,
call 1-877-643-3010.

Go Back